Tuesday, November 29, 2022
Home Partner News

Partner News

Defence's successful study on the ACCUVAC-PT007 vaccine

Defence’s successful study on the ACCUVAC-PT007 vaccine

Defence Therapeutics Inc. has announced its successful study on its ACCUVAC-PT007 vaccine, which targets cervical cancer. Defence Therapeutics Inc. a Canadian biopharmaceutical company specialised in...
LumiraDx continue rapid microfluidic immunoassay HbA1c test expansion

LumiraDx continue rapid microfluidic immunoassay HbA1c test expansion

LumiraDx's rapid microfluidic immunoassay HbA1c test will now be available in Europe, parts of the Middle East, Asia, Latin America, and Africa. Early customers...
Luxembourg government approve Azenta MoU on cold chain solutions

Luxembourg government approve Azenta MoU on cold chain solutions

Azenta, Inc. and the Government of Luxembourg today announced the signing of a Memorandum of Understanding (MoU) to facilitate continued healthcare technology and the...
Defence Therapeutics applies Accum technology to cancer vaccines

Defence Therapeutics applies Accum technology to anti-cancer vaccine

Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is initiating a new research and...
Defence Therapeutics launches new AccuTOX lung cancer treatment

Defence Therapeutics launches new AccuTOX lung cancer treatment

Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to report the start...
Secop Group and B Medical Systems announce cold chain solutions partnership

Secop Group and B Medical Systems announce cold chain solution partnership

A new agreement between Secop Group and B Medical Systems will provide new cold chain solutions for the transportation of vaccines, biospecimens and temperature-sensitive...
Defence's successful study on the ACCUVAC-PT007 vaccine

Defence Therapeutics have been granted patents for their antibody-drug conjugate technology

Defence Therapeutics is pleased to announce that notices of allowance have been issued by the Japanese and Israeli Patent Offices for patent application no....
Diagnostic technology is central to tackling pandemics

Diagnostic technology is central to tackling pandemics

“Supporting more widespread use of rapid diagnostic technology should be a central aim of efforts to tackle the next hidden pandemic” according to LumiraDx and the...
Defence Therapeutics have been granted patents for their anti drug conjugate technology

Accum A1-reprogrammed vaccine cured 80% of animals with pre-established lymphoma

Defence Therapeutics Inc, a Canadian biopharmaceutical company specialising in developing immune-oncology vaccines and drug delivery technologies, are pleased to report that Defence’s novel vaccine...
Defence Therapeutics applauds United States President on anti-cancer initiative

Defence Therapeutics applauds US President’s anti-cancer initiative

Defence Therapeutics Inc, a Canadian biotech company actively working on accelerating scientific discoveries an products development against cancer, congratulates US President, Joe Biden on...
LumiraDx COVID 19 antigen test is the only test exceeding WHO’s desirable sensitivity target

LumiraDx’s COVID-19 antigen test is the only test exceeding WHO’s desirable sensitivity target

In a Cochrane meta-analysis of 152 studies investigating over 100,000 nose and throat samples and 20 brands of COVID-19 tests, only the LumiraDx assay...
Defence’s ACCUMTM variant “A1” converts mesenchymal stromal cells into potent antigen presenting cells

Defence’s ACCUMTM variant “A1” converts mesenchymal stromal cells into potent antigen presenting cells

Defence Therapeutics has announced groundbreaking news about the development of a novel anti-cancer cellular vaccine using reprogrammed mesenchymal stromal cells. Defence Therapeutics Inc., a Canadian...
Azenta announces acquisition of B Medical Systems

Azenta announces acquisition of B Medical Systems

Azenta Inc. has announced its agreement to acquire B Medical Systems, a market leader in temperature-controlled storage and transportation solutions. In an exciting development, Azenta...
Defence's successful study on the ACCUVAC-PT007 vaccine

Defence Therapeutics receives US patent for its ADC Platform Technology

In an exciting development, Defence Therapeutics has received a US patent covering its ADC Platform Technology. In the latest announcement on August 8th, 2022, Defence...
cancer cells

ACCUTOXTM effectively eliminates cancer cells by eliciting DNA damage

In a potentially monumental breakthrough in the war against cancer, Defence Therapeutics has revealed that its leading AccuTOXTM compound effectively kills cancer cells through...
B Medical Systems

B Medical Systems appoint Thierry Goniva as Chief Technology Officer

B Medical Systems, a global pioneer of the medical cold chain industry, has announced the appointment of Thierry Goniva as Chief Technology Officer. With more...
cervical cancer vaccine

ACCUVAC-PTE7 cervical cancer vaccine provides complete protection

In a groundbreaking advancement in the treatment of cancer, Defence Therapeutics has revealed that the company’s AccuVAC-PTE7 cervical cancer vaccine completely protects against the...
Aquarate partners with Wirral council to offer hydration monitoring in care homes

Aquarate partners with Wirral council to offer hydration monitoring in care homes

Aquarate has announced a new partnership with Wirral Council to offer digital hydration monitoring across care homes. The partnership will involve the roll-out of Aquarate’s...
sustainable transport

B Medical Systems and Etihad Cargo partner to create sustainable transport for pharmaceuticals

B Medical Systems has announced that it has entered into a memorandum of understanding (MOU) with Etihad Cargo to develop sustainable transport solutions for...
blood storage

Meeting the demand for blood storage and transportation solutions

B Medical Systems, a global leader in cold chain and medical refrigeration products, predicts that there will be a surge in need for blood...

Latest Health Partners

Latest Health eBooks

Pin It on Pinterest